Pharming Group N.V. (FRA:PHGN)
Germany · Delayed Price · Currency is EUR 1.480
-0.090 (-5.73%)
At close: Jan 20, 2026
Pharming Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 0.38 | -11.84 | -10.55 | 13.67 | 16 | 37.75 |
Depreciation & Amortization | 9.83 | 10.19 | 10.13 | 9.33 | 9.17 | 8.31 |
Other Amortization | 0.85 | 0.85 | 0.88 | - | - | - |
Loss (Gain) From Sale of Assets | - | - | -21.28 | - | - | - |
Asset Writedown & Restructuring Costs | 5.03 | 5.03 | 4.92 | 3.86 | 10.44 | - |
Loss (Gain) From Sale of Investments | 0.17 | -4.99 | 0.93 | -11.06 | -0.11 | -0.07 |
Loss (Gain) on Equity Investments | 0.76 | 1.76 | 0.29 | 1.08 | -0.69 | -0.36 |
Stock-Based Compensation | 11.9 | 11.25 | 9.25 | 6.39 | 9.06 | 6.54 |
Other Operating Activities | 20.43 | -3.97 | 5.09 | -0.44 | -1.05 | 35.38 |
Change in Accounts Receivable | 6.71 | -6.78 | -18.54 | 2.36 | 5.92 | -7.04 |
Change in Inventory | 1.24 | -0.5 | -14.43 | -15.02 | -6.15 | -4.93 |
Change in Accounts Payable | -2.94 | -2.77 | 16.23 | 11.99 | -5.19 | 7.02 |
Change in Other Net Operating Assets | -1.04 | -0.02 | -0.22 | 0.27 | 0.47 | 1.04 |
Operating Cash Flow | 53.33 | -1.8 | -17.3 | 22.46 | 37.84 | 83.63 |
Operating Cash Flow Growth | 11725.28% | - | - | -40.65% | -54.75% | 12.78% |
Capital Expenditures | -0.61 | -0.79 | -1.44 | -1.38 | -10.74 | -4.66 |
Cash Acquisitions | -57.48 | - | - | - | - | - |
Sale (Purchase) of Intangibles | -0.01 | -0.01 | 21.25 | -0.6 | -5.98 | -10.64 |
Investment in Securities | 74.61 | 32.41 | -149.2 | 7.3 | -4.59 | -0.33 |
Investing Cash Flow | 16.51 | 31.62 | -129.39 | 5.32 | -21.31 | -15.63 |
Long-Term Debt Issued | - | 104.54 | - | - | - | 142.83 |
Long-Term Debt Repaid | - | -138.93 | -4.04 | -3.31 | -3.22 | -59.42 |
Net Debt Issued (Repaid) | -4.39 | -34.39 | -4.04 | -3.31 | -3.22 | 83.41 |
Issuance of Common Stock | 16.66 | 5.58 | 8.13 | 2.28 | 4.72 | 2.79 |
Other Financing Activities | -14.01 | -5.6 | -5.13 | -3.95 | -29.45 | -25.51 |
Financing Cash Flow | -1.75 | -34.41 | -1.04 | -4.98 | -27.95 | 60.69 |
Foreign Exchange Rate Adjustments | 3.62 | -2.21 | 2.13 | -7.38 | -1.83 | 2.13 |
Net Cash Flow | 71.71 | -6.8 | -145.6 | 15.42 | -13.24 | 130.81 |
Free Cash Flow | 52.72 | -2.59 | -18.74 | 21.08 | 27.1 | 78.97 |
Free Cash Flow Growth | - | - | - | -22.21% | -65.68% | 10.44% |
Free Cash Flow Margin | 14.55% | -0.87% | -7.64% | 10.25% | 13.63% | 37.22% |
Free Cash Flow Per Share | 0.08 | -0.00 | -0.03 | 0.03 | 0.04 | 0.12 |
Cash Interest Paid | 6.14 | 5.6 | 5.13 | 3.95 | 4.45 | 2.14 |
Cash Income Tax Paid | 7.19 | 15.58 | 0.66 | 1.24 | - | 2.66 |
Levered Free Cash Flow | 43.51 | 0.24 | 8.06 | 16.23 | -17.14 | 44.3 |
Unlevered Free Cash Flow | 52.45 | 5.7 | 11.78 | 19.58 | -13.33 | 48.01 |
Change in Working Capital | 3.99 | -10.07 | -16.96 | -0.39 | -4.96 | -3.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.